Catalyst Wire Dossier Catalyst Wire Dossier

MELPHALAN HYDROCHLORIDE

MELPHALAN HYDROCHLORIDE · Camber Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for MELPHALAN HYDROCHLORIDE, covering 2009-06-09 to 2025-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation [Phase 1, Phase 2]

See pricing